Literature DB >> 23098735

Repair of central nervous system lesions by transplantation of olfactory ensheathing cells.

Geoffrey Raisman1, S C Barnett, Almudena Ramón-Cueto.   

Abstract

Clinical conditions affecting the central nervous system (CNS) fall into two main categories - degenerative conditions in which nerve cells are lost (Alzheimer's, Parkinson's, Huntington's disease, etc.), and traumatic insults which sever nerve fibers but leave their cell bodies and initial parts of the severed axons intact (spinal cord injury, cerebrovascular accidents, or tumors affecting fiber tracts). After injuries of this second type, the survival of the nerve cell bodies and the local sprouting at the severed ends of the proximal stumps of the axons raise the tantalizing possibility of one day learning how to induce these severed fibers to regenerate to their original targets and restore lost functions. This chapter gives an overview of current research into the strategy of transplantation of olfactory ensheathing cells into axotomizing injuries.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23098735     DOI: 10.1016/B978-0-444-52137-8.00033-4

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  9 in total

Review 1.  Remote neurodegeneration: multiple actors for one play.

Authors:  Maria Teresa Viscomi; Marco Molinari
Journal:  Mol Neurobiol       Date:  2014-01-19       Impact factor: 5.590

2.  Voltage-dependent K+ currents contribute to heterogeneity of olfactory ensheathing cells.

Authors:  Lorena Rela; Ana Paula Piantanida; Angelique Bordey; Charles A Greer
Journal:  Glia       Date:  2015-04-09       Impact factor: 7.452

3.  Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.

Authors:  Karen L Lankford; Edgardo J Arroyo; Jeffery D Kocsis
Journal:  Neurochem Res       Date:  2017-05-11       Impact factor: 3.996

4.  Increased migration of olfactory ensheathing cells secreting the Nogo receptor ectodomain over inhibitory substrates and lesioned spinal cord.

Authors:  Diego Reginensi; Patricia Carulla; Sara Nocentini; Oscar Seira; Xavier Serra-Picamal; Abel Torres-Espín; Andreu Matamoros-Angles; Rosalina Gavín; María Teresa Moreno-Flores; Francisco Wandosell; Josep Samitier; Xavier Trepat; Xavier Navarro; José Antonio del Río
Journal:  Cell Mol Life Sci       Date:  2015-02-24       Impact factor: 9.261

Review 5.  Stem cell/cellular interventions in human spinal cord injury: Is it time to move from guidelines to regulations and legislations? Literature review and Spinal Cord Society position statement.

Authors:  Harvinder S Chhabra; Kanchan Sarda; Geeta Jotwani; M Gourie-Devi; Erkan Kaptanoglu; Susan Charlifue; S L Yadav; B Mohapatra; Abhishek Srivastava; Kedar Phadke
Journal:  Eur Spine J       Date:  2019-05-16       Impact factor: 3.134

6.  Harvesting of olfactory ensheathing cells for autologous transplantation into the spinal cord injury. Its complexity in dogs.

Authors:  Ignacio Salazar; William A Barrios Santos; Alfonso Zubizarreta; Pablo Sánchez Quinteiro
Journal:  Front Neuroanat       Date:  2015-08-25       Impact factor: 3.856

7.  Antioxidant and Anti-Senescence Effect of Metformin on Mouse Olfactory Ensheathing Cells (mOECs) May Be Associated with Increased Brain-Derived Neurotrophic Factor Levels-An Ex Vivo Study.

Authors:  Agnieszka Śmieszek; Zuzanna Stręk; Katarzyna Kornicka; Jakub Grzesiak; Christine Weiss; Krzysztof Marycz
Journal:  Int J Mol Sci       Date:  2017-04-20       Impact factor: 5.923

8.  Common olfactory ensheathing glial markers in the developing human olfactory system.

Authors:  Karen Oprych; Daniel Cotfas; David Choi
Journal:  Brain Struct Funct       Date:  2016-10-07       Impact factor: 3.270

Review 9.  Perspectives in the Cell-Based Therapies of Various Aspects of the Spinal Cord Injury-Associated Pathologies: Lessons from the Animal Models.

Authors:  Małgorzata Zawadzka; Anna Kwaśniewska; Krzysztof Miazga; Urszula Sławińska
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.